Similar Papers

Paper Title
Journal
Date
Author
Abstract PO4-16-01: EZH2 is Overexpressed in Invasive Carcinoma and DCIS in both BRCA1 and BRCA2 Mutation Carriers
Tabata Alves Domingos ... Rodrigo Fonseca Abreu
Cancer Research | VOL. 84
Tabata Alves Domingos, et. al.Tabata Alves Domingos ... Rodrigo Fonseca Abreu
02 May 2024
Exploring the Potential of Breast Microbiota as Biomarker for Breast Cancer and Therapeutic Response
Sabine Dieleman ... Marjolein Smidt
The American Journal of Pathology | VOL. 191
Sabine Dieleman, et. al.Sabine Dieleman ... Marjolein Smidt
10 Mar 2021
Ultrasound findings in pure invasive lobular carcinoma of the breast: comparison with matched cases of invasive ductal carcinoma of the breast
K.S Pointon ... D.A Cunningham
The Breast | VOL. 8
K.S Pointon, et. al.K.S Pointon ... D.A Cunningham
01 Aug 1999
Immunohistochemical detection of Her-2/neu overexpression in breast carcinoma in Nigerians: A 5-year retrospective study
Ee Ugiagbe ... De Obaseki
Nigerian Journal of Clinical Practice | VOL. 14
Ee Ugiagbe, et. al.Ee Ugiagbe ... De Obaseki
01 Jan 2010
View more papers

More From: Journal of Clinical Pathology

Paper Title
Journal
Date
Author
Mutational profile dynamics in follicular lymphoma and large cell transformation
Eva A M Hesius ... Michiel Van Den Brand
Journal of Clinical Pathology | VOL. -
Eva A M Hesius, et. al.Eva A M Hesius ... Michiel Van Den Brand
31 Jan 2025
Prevalence and breakdown of KRAS driver mutations in a large UK non-small cell lung cancer cohort
Isabella Caroline Chiara Niesner ... David Allan Moore
Journal of Clinical Pathology | VOL. -
Isabella Caroline Chiara Niesner, et. al.Isabella Caroline Chiara Niesner ... David Allan Moore
31 Jan 2025
The prevalence of PD-L1 expression in patients with advanced oesophageal cancer: the EXCEED observational study
Liyan Xue ... Jianming Ying
Journal of Clinical Pathology | VOL. -
Liyan Xue, et. al.Liyan Xue ... Jianming Ying
28 Jan 2025
Computational pathology identifies a low B-cell content in the tumour microenvironment as a predictor of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD
Antonio Santisteban-Espejo ... Marcial Garcia-Rojo
Journal of Clinical Pathology | VOL. -
Antonio Santisteban-Espejo, et. al.Antonio Santisteban-Espejo ... Marcial Garcia-Rojo
20 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.